GlassScriptPhysician profile
Florencia Perez
NPI 1689715500
$1,662.77
in general payments reported to CMS, 2019-2025
17 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.54 · 2020: $165 · 2021: $285 · 2022: $145 · 2023: $342 · 2024: $381 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $977.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $511.81 | 2020-2025 | Jardiance, Mounjaro, Trulicity |
| Novo Nordisk INC | $268.17 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $230.38 | 2024-2025 | Freestyle Libre 3 |
| Pfizer INC. | $114.42 | 2019-2024 | |
| Cumberland Pharmaceuticals, INC. | $102.93 | 2019-2023 | Kristalose |
| Abbvie INC. | $85.79 | 2023-2024 | |
| Amgen INC. | $74.35 | 2021-2025 | Repatha, Otezla, Evenity |
| Astrazeneca Pharmaceuticals LP | $58.70 | 2019-2024 | Airsupra |
| Genentech USA, INC. | $49.13 | 2020-2021 | |
| Phadia US INC. | $32.20 | 2022-2024 | Immunocap |
| Evofem Biosciences, INC. | $29.95 | 2022-2023 | Phexxi |
| Glaxosmithkline, LLC. | $25.29 | 2024 | Trelegy Ellipta |
| Axsome Therapeutics, INC. | $17.53 | 2025 | Auvelity |
| Astellas Pharma US INC | $16.50 | 2024 | Veozah |
| Dexcom, INC. | $15.99 | 2025 | Dexcom G6 Transmitter |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $15.37 | 2019 | |
| Organon LLC | $14.26 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Florencia Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.